Monopar Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNPR and other ETFs, options, and stocks.

About MNPR

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. 

CEO
Chandler Drew Robinson
CEOChandler Drew Robinson
Employees
16
Employees16
Headquarters
Wilmette, Illinois
HeadquartersWilmette, Illinois
Founded
2014
Founded2014
Employees
16
Employees16

MNPR Key Statistics

Market cap
265.10M
Market cap265.10M
Price-Earnings ratio
-10.81
Price-Earnings ratio-10.81
Dividend yield
—
Dividend yield—
Average volume
17.11K
Average volume17.11K
High today
$44.57
High today$44.57
Low today
$39.35
Low today$39.35
Open price
$41.64
Open price$41.64
Volume
13.15K
Volume13.15K
52 Week high
$54.30
52 Week high$54.30
52 Week low
$1.72
52 Week low$1.72
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.